TrialThe Lancet. Infectious diseases2015

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.

Michael T White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.